Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: Results from a crossover study

Tohru Noguchi, Hiroshi Mabuchi, Kunimasa Yagi et al.|Atherosclerosis|2011

Cited by 40